The use of implantable venous access devices (IVADs) in children with hemophilia

Implantable venous access devices (IVADs), either centrally or peripherally implanted, have become increasingly popular in children with hemophilia to assist in the early treatment of bleeding episodes and in the prevention of arthropathy. Their use has been associated with complications including t...

Full description

Saved in:

Bibliographic Details
Published in:	Journal of pediatric hematology/oncology Vol. 19; no. 4; pp. 339 - 344
Main Authors:	PERKINS, J. L, JOHNSON, V. A, OSIP, J. M, CHRISTIE, B. A, NELSON, S. C, MOERTEL, C. L, HEISEL, M. A
Format:	Journal Article
Language:	English
Published:	Hagerstown, MD Lippincott 01-07-1997
Subjects:	Adolescent Biological and medical sciences Catheterization, Central Venous - adverse effects Catheterization, Central Venous - instrumentation Catheterization, Central Venous - methods Catheterization, Peripheral - adverse effects Catheterization, Peripheral - instrumentation Catheterization, Peripheral - methods Catheters, Indwelling - adverse effects Child Child, Preschool Hemophilia A - therapy Humans Infant Male Medical sciences Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases Vascular surgery: aorta, extremities, vena cava. Surgery of the lymphatic vessels Human Device Hemopathy Genetic disease Direct access Surgical implantation Follow up study Surgery Hemophilia Complication Vein Child Coagulopathy
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Description
Summary:	Implantable venous access devices (IVADs), either centrally or peripherally implanted, have become increasingly popular in children with hemophilia to assist in the early treatment of bleeding episodes and in the prevention of arthropathy. Their use has been associated with complications including thrombosis, thrombophlebitis, and infection. We attempted to better define whether the benefits associated with IVADs in this population outweight the associated risks. We studied the medical records of 35 children from the University of Minnesota's Comprehensive Hemophilia Center who received IVADs between 1992 and 1996. There was no bleeding or thrombophlebitis associated with IVADs in our population. One patient required removal of a central IVAD due to thrombosis. The central IVADs were associated with local infection and bacteremia rates of 3% and 33%, respectively. The rates of local infection and bacteremia associated with peripheral IVADs were both 25%. The majority of infections were cleared with antibiotics, and ports remained intact. Both types of IVADs were associated with a high patient/parent satisfaction. Despite being associated with a significant incidence of infection, we believe the benefits of IVADs for children with hemophilia and their families outweigh the risks. Possible explanations for the observed infection rates are discussed.
Bibliography:	ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23
ISSN:	1077-4114 1536-3678
DOI:	10.1097/00043426-199707000-00013